Key result
Pulsed field ablation is feasible for AF in type 1 von Willebrand disease with factor supplementation.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Demonstrates the feasibility of pulsed field ablation for paroxysmal atrial fibrillation in a patient with a bleeding disorder (type 1 von Willebrand disease) using appropriate perioperative factor supplementation.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and a major risk factor for stroke and heart failure. 1 Catheter ablation with pulmonary vein isolation (PVI) is an established rhythm-control strategy for drug-refractory paroxysmal AF. 2 Pulsed field ablation (PFA), a novel nonthermal ablation modality that induces irreversible electroporation of cardiomyocytes using ultrashort high-voltage electrical pulses, has demonstrated favorable efficacy and safety profiles due to its tissue-selective characteristics.
No takes yet. Share an insight, caveat, or question.
Endo et al. (2026) conducted a case report in Paroxysmal atrial fibrillation and type 1 von Willebrand disease (n=1). Pulsed field ablation with perioperative recombinant human von Willebrand factor supplementation was evaluated. Pulsed field ablation was successfully performed in a patient with paroxysmal atrial fibrillation and type 1 von Willebrand disease using perioperative recombinant factor supplementation.
Synapse has enriched 10 related papers. Consider them for comparative context: